Related Experiment Video
Updated: Aug 15, 2026

Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
The modular adaptor protein autosomal recessive hypercholesterolemia (ARH) promotes low density lipoprotein receptor
Rita Garuti1, Christopher Jones, Wei-Ping Li
1Department of Molecular Genetics, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390-8591, USA.
Insights
Autosomal recessive hypercholesterolemia involves a defect in low-density lipoprotein receptor (LDLR) uptake. The ARH protein requires binding to the LDLR tail and either clathrin or AP-2 to enable LDL internalization.
Area of Science:
- Cell biology
- Molecular genetics
- Biochemistry
Background:
- Autosomal recessive hypercholesterolemia presents a cell-specific defect in low-density lipoprotein receptor (LDLR) endocytosis.
- This impairment in LDLR-mediated LDL uptake is observed in the liver but not in fibroblasts.
Purpose of the Study:
- To investigate the physiological relevance of ARH protein interactions with the LDLR and endocytic machinery.
- To determine the specific domains and interactions of ARH necessary for LDLR clustering and internalization.
Main Methods:
- Utilized polarized hepatocytes (WIF-B) to study the effect of ARH mutations on LDLR localization and function.
- Employed in vivo studies using Arh(-/-) mice and recombinant ARH to validate cell culture findings.
Main Results:
- The integrity of the FDNPVY sequence in the LDLR cytoplasmic tail is crucial for ARH-associated LDLR clustering into clathrin-coated pits.
- ARH's phosphotyrosine binding domain, along with its clathrin box or AP-2 binding region, is essential for LDLR clustering and internalization.
- In vivo studies in mice confirmed the necessity of these ARH interactions for LDLR function.
Conclusions:
- ARH protein acts as a critical adaptor, linking the LDLR to the clathrin-mediated endocytic pathway.
- Successful LDL internalization requires ARH to bind the LDLR tail and interact with either clathrin or AP-2.
Abstract:
Autosomal recessive hypercholesterolemia is characterized by a cell type-specific defect in low density lipoprotein receptor (LDLR) endocytosis. LDLR-mediated uptake of LDL is impaired in the liver, but not in fibroblasts of subjects with this disorder. The disease is caused by mutations in ARH, which encodes a putative adaptor protein that interacts with the cytoplasmic tail of the LDLR, phospholipids, and two components of the clathrin endocytic machinery, clathrin and adaptor protein-2 (AP-2) in vitro. To determine the physiological relevance of these interactions, we examined the effect of mutations in the ARH on LDLR location and function in polarized hepatocytes (WIF-B). The integrity of the FDNPVY sequence in the LDLR cytoplasmic tail was required for ARH-associated LDLR clustering into clathrin-coated pits. The phosphotyrosine binding domain of ARH plus either the clathrin box or the AP-2 binding region were required for both clustering and internalization of the LDLR. Parallel studies performed in vivo with the same recombinant forms of ARH in livers of Arh(-/-) mice confirmed the relevance of the cell culture findings. These results demonstrate that ARH must bind the LDLR tail and either clathrin or AP-2 to promote receptor clustering and internalization of LDL.
More Related Videos
Related Concept Videos
Receptor-mediated Endocytosis
Receptor-mediated Endocytosis
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Clathrin Coated Vesicles
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Regulation of Nuclear Protein Sorting
